Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Brittinger

Showing results (141-150 of 163) with videos related to

Pageof 17
Sort By:
Humangenetik|January 1, 1971
Evidence for linkage between the locus for the ABO-system and the locus for phosphoglucoseisomerase (PGI)H Ritter, G Tariverdian, H Arnold, et al.
Onkologie|February 1, 1988
[Multicenter prospective risk-adapted study on the therapy of non-Hodgkin's lymphomas of high malignancy. Use of COP-BLAM/IMVP-16 and randomized adjuvant radiotherapy--study concept and preliminary results]W Siegert, D Huhn, A Neubauer, et al.
Leukemia & Lymphoma|March 18, 2000
Multicenter phase II study of oral idarubicin in treated and untreated patients with B-chronic lymphocytic leukemiaB Gahn, G Brittinger, G Dölken, et al.
Blood|October 15, 1993
Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomasH H Gerhartz, M Engelhard, P Meusers, et al.
Onkologie|April 1, 1986
[Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas]G Brittinger, H Bartels, H Common, et al.
Klinische Wochenschrift|September 15, 1987
Lupus anticoagulant associated syndrome in benign and malignant systemic disease--analysis of ten observationsU Dührsen, D Paar, C Kölbel, et al.
Hematological Oncology|July 1, 1984
Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study GroupG Brittinger, H Bartels, H Common, et al.
Lancet (London, England)|April 8, 1972
Response to phytohaemagglutinin and pokeweed mitogen in chronic lymphocytic leukemiaD Catovsky, E Tripp, A V Hoffbrand, et al.
Seminars in Oncology|December 1, 1994
Recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to chemotherapy in aggressive non-Hodgkin's lymphomasH H Gerhartz, M Engelhard, G Brittinger, et al.
Strahlentherapie|April 1, 1977
[Retrospective analysis of the clinical relevance of the Kiel classification of malignant non-Hodgkin's lymphomas (author's transl)]G Brittinger, H Bartels, K Bremer, et al.
Pageof 17

Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
Humangenetik|January 1, 1971
Evidence for linkage between the locus for the ABO-system and the locus for phosphoglucoseisomerase (PGI)H Ritter, G Tariverdian, H Arnold, et al.
Onkologie|February 1, 1988
[Multicenter prospective risk-adapted study on the therapy of non-Hodgkin's lymphomas of high malignancy. Use of COP-BLAM/IMVP-16 and randomized adjuvant radiotherapy--study concept and preliminary results]W Siegert, D Huhn, A Neubauer, et al.
Leukemia & Lymphoma|March 18, 2000
Multicenter phase II study of oral idarubicin in treated and untreated patients with B-chronic lymphocytic leukemiaB Gahn, G Brittinger, G Dölken, et al.
Blood|October 15, 1993
Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomasH H Gerhartz, M Engelhard, P Meusers, et al.
Onkologie|April 1, 1986
[Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas]G Brittinger, H Bartels, H Common, et al.
Klinische Wochenschrift|September 15, 1987
Lupus anticoagulant associated syndrome in benign and malignant systemic disease--analysis of ten observationsU Dührsen, D Paar, C Kölbel, et al.
Hematological Oncology|July 1, 1984
Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study GroupG Brittinger, H Bartels, H Common, et al.
Lancet (London, England)|April 8, 1972
Response to phytohaemagglutinin and pokeweed mitogen in chronic lymphocytic leukemiaD Catovsky, E Tripp, A V Hoffbrand, et al.
Seminars in Oncology|December 1, 1994
Recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to chemotherapy in aggressive non-Hodgkin's lymphomasH H Gerhartz, M Engelhard, G Brittinger, et al.
Strahlentherapie|April 1, 1977
[Retrospective analysis of the clinical relevance of the Kiel classification of malignant non-Hodgkin's lymphomas (author's transl)]G Brittinger, H Bartels, K Bremer, et al.
Pageof 17